Trustmark Corporation
NASDAQ:TRMKBanks - Regional
+$0.53 today
- Market cap
- $2.66B
- Beta
- 0.65
- P/E (TTM)
- 11.6
- EPS (TTM)
- $3.85
- Dividend yield
- 2.19%
Volume 0.90M
Average 0.38M
TRMK Cash & Equivalents
Cash on hand and highly liquid investments that can be converted to cash almost immediately.
Trustmark CorporationNASDAQ: TRMK
Cash & Equivalents · Q3 FY2026 · quarter ended Sep 2026
Cash & equivalents falls 3.1% from a year ago
Cash & equivalents stood at $710.17M at the end of Q3 FY2026, down 3.1% from a year earlier and up 6.0% from the prior quarter. Over 3 fiscal years it compounded at -3.1% a year.
Context
- Cash & equivalents amounted to 3.7% of total assets at the end of Q3 FY2026, down 0.2 pp from a year earlier.
- Cash & equivalents increased in 2 of the last 3 fiscal years.
What to watch
Whether cash & equivalents keeps falling in the next quarterly balance sheet after a -3.1% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Cash & Equivalents history
USD · from the balance sheet
- Latest · FY2025
- 668.01M USD
- Year-over-year change
- +17.8%
- 4-year CAGR
- -26.3%
| Period | Period end | Cash & Equivalents | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 668.01M | +17.8% |
| FY2024 | 2024-12-31 | 567.25M | -41.8% |
| FY2023 | 2023-12-31 | 975.34M | +32.7% |
| FY2022 | 2022-12-31 | 734.79M | -67.6% |
| FY2021 | 2021-12-31 | 2.27B | — |
Cash & Equivalents vs competitors
How TRMK compares with its peers on the latest reported figures
- TRMK's Sep 2026 cash & equivalents of $710.17M is the 2nd highest of the 11 companies compared; the peer median is $133.89M.
- Its year-over-year change of -3.1% is the 4th highest of 11, against a peer median of -17.9%.
- Cash & equivalents amounts to 3.7% of total assets for TRMK, versus a peer median of 2.2%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Sep 2026 | $734.52M | -32.2% | +23.0% | 2.7% | |
| Sep 2026 | $710.17M | -3.1% | -3.1% | 3.7% | |
| Sep 2026 | $566.77M | +115.6% | +23.6% | 4.7% | |
| Mar 2026 | $358.9M | +5.3% | -21.3% | 5.3% | |
| Sep 2026 | $215.47M | -66.3% | -2.1% | 1.3% | |
| Sep 2026 | $149.03M | -31.9% | -10.2% | 1.2% | |
| Mar 2026 | $118.76M | +66.3% | -18.4% | 5.9% | |
| Mar 2026 | $93.64M | -24.2% | -50.3% | 2.9% | |
| Mar 2026 | $82.22M | -6.7% | -4.3% | 1.8% | |
| Mar 2026 | $43.17M | -11.5% | +5.2% | 0.7% | |
| Mar 2026 | $27.78M | -76.1% | -36.6% | 0.4% | |
| Peer median (excluding TRMK) | $133.89M | -17.9% | -7.3% | 2.2% | |
Competitors are the stored peer set for TRMK. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 2.27B | 734.79M | 975.34M | 567.25M | 668.01M |
| Short-term Investments | 3.24B | 2.02B | 1.76B | 1.69B | 1.88B |
| Net Receivables | 0 | 0 | 0 | 0 | 0 |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 0 | 0 | 0 | 0 | 0 |
| Total Current Assets | 5.51B | 2.76B | 2.74B | 2.26B | 2.54B |
| Property, Plant & Equipment (Net) | 236.52M | 248.67M | 266.74M | 270.08M | 257.81M |
| Goodwill | 384.24M | 384.24M | 334.61M | 334.61M | 334.61M |
| Intangible Assets | 92.76M | 133.32M | 132.11M | 139.44M | 0 |
| Long-term Investments | 10.8B | 13.71B | 14.49B | 14.47B | 0 |
| Tax Assets | 99.82M | 0 | 0 | 0 | 0 |
| Other Non-current Assets | 472.91M | 776.82M | 759.44M | 682.18M | 36.25M |
| Total Non-current Assets | 12.09B | 15.26B | 15.98B | 15.89B | 628.67M |
| Total Assets | 17.6B | 18.02B | 18.72B | 18.15B | 18.93B |
| Account Payables | 0 | 0 | 0 | 0 | 0 |
| Short-term Debt | 323.04M | 520.14M | 484.58M | 421.64M | 445M |
| Tax Payables | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 15.09B | 14.44B | 15.57B | 15.11B | 3.04B |
| Total Current Liabilities | 15.41B | 14.96B | 16.05B | 15.53B | 3.48B |
| Long-term Debt | 185M | 1.16B | 585.4M | 385.56M | 634.83M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 216.2M | 361.24M | 377.17M | 232.12M | 12.65B |
| Total Non-current Liabilities | 444.12M | 1.57B | 1.01B | 660.28M | 13.32B |
| Total Liabilities | 15.85B | 16.52B | 17.06B | 16.19B | 16.8B |
| Common Stock | 12.85M | 12.71M | 12.73M | 12.71M | 12.3M |
| Retained Earnings | 1.59B | 1.6B | 1.71B | 1.88B | 2.04B |
| Accumulated OCI | (32.56M) | (275.4M) | (219.72M) | (83.66M) | (13.63M) |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 1.74B | 1.49B | 1.66B | 1.96B | 2.12B |
| Total Debt | 550.97M | 1.72B | 1.11B | 849.81M | 1.12B |
| Net Debt | (1.72B) | 989.53M | 138.07M | 282.55M | 448.08M |
Trustmark Corporation
NASDAQ:TRMK
Intrinsic Alpha fair value
Locked
Current Price
$45.99
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.